LIMN
Liminatus Pharma, Inc. Class A Common Stock
LIMN
LIMN
10 hedge funds and large institutions have $2.28M invested in Liminatus Pharma, Inc. Class A Common Stock in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$819K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$712K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$351K |
| 4 |
State Street
Boston,
Massachusetts
|
+$212K |
| 5 |
BlackRock
New York
|
+$148K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $819K | +$819K | +73,424 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $712K | +$712K | +63,841 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $351K | +$351K | +31,486 | New |
|
|
4
State Street
Boston,
Massachusetts
| $212K | +$212K | +19,000 | New |
|
|
5
BlackRock
New York
| $148K | +$148K | +13,255 | New |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $32K | +$32K | +2,886 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $5.66K | +$5.66K | +508 | New |
|
8
Barclays
London,
United Kingdom
| $2K | +$2K | +184 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $735 | +$735 | +66 | New |
|
|
SS
10
SBI Securities
Tokyo,
Japan
| $580 | +$580 | +52 | New |
|